National Institute on Minority Health and Health Disparities; Notice of Meeting, 8537-8538 [2017-01738]
Download as PDF
<![CDATA[
Federal Register / Vol. 82, No. 16 / Thursday, January 26, 2017 / Notices
Health, 6701 Rockledge Drive , Room 3172,
Bethesda, MD 20892, cowleshw@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: January 19, 2017.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–01739 Filed 1–25–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meetings
jstallworth on DSK7TPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel;
Coordinating Center for the HIV/AIDS and
Substance Use Cohorts Program (U24).
Date: February 17, 2017.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate
cooperative agreement applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852, (Telephone
Conference Call).
Contact Person: Hiromi Ono, Ph.D.,
Scientific Review Officer, Office of
Extramural Affairs, National Institute on
Drug Abuse, National Institutes of Health,
DHHS, 6001 Executive Boulevard, Room
4238, MSC 9550, Bethesda, MD 20892, (301)
827–5820, hiromi.ono@nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; R13
Conference Grant Review.
Date: February 17, 2017.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852, (Virtual
Meeting).
Contact Person: Susan O. McGuire, Ph.D.,
Scientific Review Officer, Office of
VerDate Sep<11>2014
15:10 Jan 25, 2017
Jkt 241001
Extramural Affairs, National Institute on
Drug Abuse, National Institutes of Health,
DHHS, 6001 Executive Blvd., Room 4245,
Rockville, MD 20852, (301) 827–5817,
mcguireso@mail.nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel;
Exploratory Studies of Smoking Cessation
Interventions for People with Schizophrenia
(R21/R33).
Date: February 27, 2017.
Time: 12:00 p.m. to 12:45 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852, (Telephone
Conference Call).
Contact Person: Hiromi Ono, Ph.D.,
Scientific Review Officer, Office of
Extramural Affairs, National Institute on
Drug Abuse, National Institutes of Health,
DHHS, 6001 Executive Boulevard, Room
4238, MSC 9550, Bethesda, MD 20892, (301)
827–5820, hiromi.ono@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos.: 93.279, Drug Abuse and
Addiction Research Programs, National
Institutes of Health, HHS)
Dated: January 19, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–01737 Filed 1–25–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Integrative
Nutrition and Metabolic Processes.
Date: February 9, 2017.
Time: 3:00 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Washington Marriott at Metro
Center, 775 12th Street NW., Washington, DC
20005.
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
8537
Contact Person: Michael Knecht, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6176,
MSC 7892, Bethesda, MD 20892, (301) 435–
1046, knechtm@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Molecular
Mechanisms of Cell Death and Disease.
Date: February 16, 2017.
Time: 2:00 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Carole L. Jelsema, Ph.D.,
Chief and Scientific Review Administrator,
MDCN Scientific Review Group, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4146,
MSC 7850, Bethesda, MD 20892, (301) 435–
1248, jelsemac@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Innate Immune Responses.
Date: February 17, 2017.
Time: 2:30 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Ritz-Carlton Hotel at Pentagon City,
1250 South Hayes Street, Arlington, VA
22202.
Contact Person: Tina McIntyre, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4202,
MSC 7812, Bethesda, MD 20892, 301–594–
6375, mcintyrt@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: January 19, 2017.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–01735 Filed 1–25–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Minority Health
and Health Disparities; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Advisory Council on Minority
Health and Health Disparities.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
E:\FR\FM\26JAN1.SGM
26JAN1
8538
Federal Register / Vol. 82, No. 16 / Thursday, January 26, 2017 / Notices
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contract proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications and/or contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
jstallworth on DSK7TPTVN1PROD with NOTICES
Name of Committee: National Advisory
Council on Minority Health and Health
Disparities.
Date: February 27–28, 2017.
Closed: February 27, 2017, 3:00 p.m. to
adjournment.
Agenda: To review and evaluate grant
applications and/or proposals.
Place: National Institutes of Health, 31
Center Drive, Building 31, Conference Room
10, Bethesda, MD 20892.
Open: February 28, 2017, 8:00 a.m. to
adjournment.
Agenda: The agenda will include opening
remarks, administrative matters, Director’s
report, NIH Health Disparities update, and
other business of the Council.
Place: National Institutes of Health, 31
Center Drive, Building 31, Conference Room
10, Bethesda, MD 20892.
Contact Person: Dr. Joyce A. Hunter,
Deputy Director, NIMHD, National Institutes
of Health, National Institute on Minority
Health and Heath Disparities, 6707
Democracy Blvd., Suite 800, Bethesda, MD
20892, (301) 402–1366, hunterj@nih.gov.
Any member of the public interested
in presenting oral comments to the
committee may notify the Contact
Person listed on this notice at least 10
days in advance of the meeting.
Interested individuals and
representatives of organizations may
submit a letter of intent, a brief
description of the organization
represented, and a short description of
the oral presentation. Only one
representative of an organization may be
allowed to present oral comments and if
accepted by the committee,
presentations may be limited to five
minutes. Both printed and electronic
copies are requested for the record. In
addition, any interested person may file
written comments with the committee
by forwarding their statement to the
Contact Person listed on this notice. The
statement should include the name,
address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
VerDate Sep<11>2014
15:10 Jan 25, 2017
Jkt 241001
In the interest of security, NIH has
instituted stringent procedures for
entrance onto the NIH campus. All
visitor vehicles, including taxis, hotel,
and airport shuttles, will be inspected
before being allowed on campus.
Visitors will be asked to show one form
of identification (for example, a
government-issued photo ID, driver’s
license, or passport) and to state the
purpose of their visit.
Dated: January 19, 2017.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–01738 Filed 1–25–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Integrative,
Functional and Cognitive Neuroscience
Integrated Review Group; Neurobiology of
Learning and Memory Study Section.
Date: February 21, 2017.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: DoubleTree by Hilton Hotel Los
Angeles—Westside, 6161 W Centinela
Avenue, Culver City, CA 90230.
Contact Person: Nicholas Gaiano, PhD.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5178,
MSC 7844, Bethesda, MD 20892–7844, 301–
435–1033, gaianonr@csr.nih.gov.
Name of Committee: Integrative,
Functional and Cognitive Neuroscience
Integrated Review Group; Mechanisms of
Sensory, Perceptual, and Cognitive Processes
Study Section.
Date: February 21–22, 2017.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
Place: Argonaut Hotel, 495 Jefferson Street,
San Francisco, CA 94109.
Contact Person: Kirk Thompson, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5184,
MSC 7844, Bethesda, MD 20892, 301–435–
1242, kgt@mail.nih.gov.
Name of Committee: Biobehavioral and
Behavioral Processes Integrated Review
Group; Biobehavioral Mechanisms of
Emotion, Stress and Health Study Section.
Date: February 21–22, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: JW Marriott New Orleans, 614 Canal
Street, New Orleans, LA 70130.
Contact Person: Samantha Smith, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive Room 3170,
Bethesda, MD 20892, samanthasmith@
csr.nih.gov.
Name of Committee: Population Sciences
and Epidemiology Integrated Review Group;
Cancer, Heart, and Sleep Epidemiology B
Study Section.
Date: February 21–22, 2017.
Time: 8:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Pier 2620 Hotel, 2620 Jones Street,
San Francisco, CA 94133.
Contact Person: Ellen K. Schwartz, EDD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3144,
MSC 7770, Bethesda, MD 20892, 301–828–
6146, schwarel@mail.nih.gov.
Name of Committee: Oncology 1—Basic
Translational Integrated Review Group;
Tumor Progression and Metastasis Study
Section.
Date: February 21–22, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hotel Solamar, 435 6th Avenue, San
Diego, CA 92101.
Contact Person: Rolf Jakobi, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6187,
MSC 7806, Bethesda, MD 20892, 301–495–
1718, jakobir@mail.nih.gov.
Name of Committee: Healthcare Delivery
and Methodologies Integrated Review Group;
Health Services Organization and Delivery
Study Section.
Date: February 21–22, 2017.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW.,
Washington, DC 20015.
Contact Person: Jacinta Bronte-Tinkew,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3164,
MSC 7770, Bethesda, MD 20892, (301) 806–
0009, brontetinkewjm@csr.nih.gov.
Name of Committee: Infectious Diseases
and Microbiology Integrated Review Group;
Vector Biology Study Section.
E:\FR\FM\26JAN1.SGM
26JAN1
]]>Agencies
[Federal Register Volume 82, Number 16 (Thursday, January 26, 2017)]
[Notices]
[Pages 8537-8538]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-01738]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Minority Health and Health Disparities;
Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
National Advisory Council on Minority Health and Health Disparities.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign
[[Page 8538]]
language interpretation or other reasonable accommodations, should
notify the Contact Person listed below in advance of the meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and/or contract proposals
and the discussions could disclose confidential trade secrets or
commercial property such as patentable material, and personal
information concerning individuals associated with the grant
applications and/or contract proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Advisory Council on Minority Health
and Health Disparities.
Date: February 27-28, 2017.
Closed: February 27, 2017, 3:00 p.m. to adjournment.
Agenda: To review and evaluate grant applications and/or
proposals.
Place: National Institutes of Health, 31 Center Drive, Building
31, Conference Room 10, Bethesda, MD 20892.
Open: February 28, 2017, 8:00 a.m. to adjournment.
Agenda: The agenda will include opening remarks, administrative
matters, Director's report, NIH Health Disparities update, and other
business of the Council.
Place: National Institutes of Health, 31 Center Drive, Building
31, Conference Room 10, Bethesda, MD 20892.
Contact Person: Dr. Joyce A. Hunter, Deputy Director, NIMHD,
National Institutes of Health, National Institute on Minority Health
and Heath Disparities, 6707 Democracy Blvd., Suite 800, Bethesda, MD
20892, (301) 402-1366, hunterj@nih.gov.
Any member of the public interested in presenting oral comments to
the committee may notify the Contact Person listed on this notice at
least 10 days in advance of the meeting. Interested individuals and
representatives of organizations may submit a letter of intent, a brief
description of the organization represented, and a short description of
the oral presentation. Only one representative of an organization may
be allowed to present oral comments and if accepted by the committee,
presentations may be limited to five minutes. Both printed and
electronic copies are requested for the record. In addition, any
interested person may file written comments with the committee by
forwarding their statement to the Contact Person listed on this notice.
The statement should include the name, address, telephone number and
when applicable, the business or professional affiliation of the
interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxis, hotel, and airport shuttles, will be inspected before
being allowed on campus. Visitors will be asked to show one form of
identification (for example, a government-issued photo ID, driver's
license, or passport) and to state the purpose of their visit.
Dated: January 19, 2017.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-01738 Filed 1-25-17; 8:45 am]
BILLING CODE 4140-01-P
